Thomas Tan
Inversor de Capital Privado en Lundbeckfonden Ventures .
Cargos activos de Thomas Tan
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Lundbeckfonden Ventures
Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Inversor de Capital Privado | 01/01/2021 | - |
Sound Bioventures Management ApS | Inversor de Capital Privado | 01/04/2022 | - |
Sound Bioventures Management AB
Sound Bioventures Management AB Investment ManagersFinance Sound Bioventures Management AB is a venture capital firm founded in 2021 by Casper Breum, Johan Kordel and Bibhash Mukhopadhyay. The firm is headquartered in Malmo, Sweden. | Inversor de Capital Privado | 01/01/2022 | - |
Historial de carrera de Thomas Tan
Antiguos cargos conocidos de Thomas Tan.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Director/Miembro de la Junta | 01/10/2021 | 30/04/2022 |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Director/Miembro de la Junta | 01/10/2021 | 30/04/2022 |
Lifescience Dynamics Ltd. | Corporate Officer/Principal | 01/07/2020 | 31/01/2021 |
Huron Consulting Services U.K. Ltd.
Huron Consulting Services U.K. Ltd. Miscellaneous Commercial ServicesCommercial Services Pope Woodhead & Associates Ltd. provides management consultancy services. The company was founded on November 9, 2006 and is headquartered in Saint Ivens, the United Kingdom. | Corporate Officer/Principal | 01/01/2019 | 31/07/2020 |
Formación de Thomas Tan.
University of Oxford | Doctorate Degree |
University of Copenhagen | Graduate Degree |
Estadísticas
Internacional
Dinamarca | 4 |
Reino Unido | 4 |
Países Bajos | 2 |
Operativa
Private Equity Investor | 3 |
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Sectorial
Finance | 4 |
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 7 |
---|---|
Varmx BV
Varmx BV BiotechnologyHealth Technology VarmX BV is a spin-off from Leiden University Medical Center (LUMC) founded in 2016 by Professor Pieter Reitsma, a world-leading expert in hemostasis and thrombosis. VarmX is based in Leiden, NL. The Dutch company's lead compound, VMX-C001, is a modified recombinant blood factor X developed for the treatment of severe spontaneous bleeding and for the prevention of bleeding during urgent surgery in patients taking oral factor Xa inhibitors (FXa DOACs) as anticoagulation therapy. The company is supported by a strong syndicate of investors. Jan K. Öhrström has been the CEO of the company since 2018. | Health Technology |
Atox Bio Ltd.
Atox Bio Ltd. BiotechnologyHealth Technology Atox Bio, Inc. provides novel immune modulators for critically ill patients with severe infections. The firm discovers and develops novel immune modulators for critically ill patients with severe infections. Its main product is AB103, a novel immune modulator. The company was founded by Raymond Kaempfer and Gila Arad in 2003 and is headquartered in Ness Ziona, Israel. | Health Technology |
Lundbeckfonden Ventures
Lundbeckfonden Ventures Investment ManagersFinance Lundbeckfonden Ventures (Lundbeckfonden Ventures) is a venture capital firm wholly-owned by the Lundbeck Foundation. The firm was established in 2009 and is headquartered in Copenhagen, Denmark. | Finance |
Lifescience Dynamics Ltd. | |
Huron Consulting Services U.K. Ltd.
Huron Consulting Services U.K. Ltd. Miscellaneous Commercial ServicesCommercial Services Pope Woodhead & Associates Ltd. provides management consultancy services. The company was founded on November 9, 2006 and is headquartered in Saint Ivens, the United Kingdom. | Commercial Services |
Sound Bioventures Management ApS | Finance |
Sound Bioventures Management AB
Sound Bioventures Management AB Investment ManagersFinance Sound Bioventures Management AB is a venture capital firm founded in 2021 by Casper Breum, Johan Kordel and Bibhash Mukhopadhyay. The firm is headquartered in Malmo, Sweden. | Finance |
- Bolsa de valores
- Insiders
- Thomas Tan
- Experiencia